Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Local News Matters on MSN
A playbook for newsrooms: Revolutionizing election coverage with AI part II
Our Goal In the fast-evolving landscape of AI, we saw an opportunity to revolutionize local election coverage in our newsroom ...
Local News Matters on MSN
A playbook for newsrooms: Revolutionizing election coverage with AI
Our Goal In the fast-evolving landscape of AI, we saw an opportunity to revolutionize local election coverage in our newsroom by reducing manual, repetitive tasks so our journalists could focus on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results